These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22686577)

  • 1. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
    Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K
    ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide.
    Brambilla D; Verpillot R; Taverna M; De Kimpe L; Le Droumaguet B; Nicolas J; Canovi M; Gobbi M; Mantegazza F; Salmona M; Nicolas V; Scheper W; Couvreur P; Andrieux K
    Anal Chem; 2010 Dec; 82(24):10083-9. PubMed ID: 21086977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
    Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
    Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
    Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
    ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.
    Gobbi M; Re F; Canovi M; Beeg M; Gregori M; Sesana S; Sonnino S; Brogioli D; Musicanti C; Gasco P; Salmona M; Masserini ME
    Biomaterials; 2010 Sep; 31(25):6519-29. PubMed ID: 20553982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
    Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
    Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic.
    Brambilla D; Verpillot R; De Kimpe L; Taverna M; Le Droumaguet B; Nicolas J; Canovi M; Gobbi M; Salmona M; Nicolas V; Scheper W; Couvreur P; Andrieux K
    J Control Release; 2010 Nov; 148(1):e112-3. PubMed ID: 21529583
    [No Abstract]   [Full Text] [Related]  

  • 10. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide.
    Brambilla D; Souguir H; Nicolas J; Mackiewicz N; Verpillot R; Le Droumaguet B; Taverna M; Couvreur P; Andrieux K
    J Biotechnol; 2011 Dec; 156(4):338-40. PubMed ID: 21807038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
    Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
    Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.
    Richman M; Wilk S; Skirtenko N; Perelman A; Rahimipour S
    Chemistry; 2011 Sep; 17(40):11171-7. PubMed ID: 21887833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
    Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
    Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
    Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
    Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of human proteins to amyloid-β protofibrils.
    Rahman MM; Zetterberg H; Lendel C; Härd T
    ACS Chem Biol; 2015 Mar; 10(3):766-74. PubMed ID: 25469473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity.
    Lindgren J; Segerfeldt P; Sholts SB; Gräslund A; Karlström AE; Wärmländer SK
    J Inorg Biochem; 2013 Mar; 120():18-23. PubMed ID: 23262458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles.
    Cabaleiro-Lago C; Quinlan-Pluck F; Lynch I; Lindman S; Minogue AM; Thulin E; Walsh DM; Dawson KA; Linse S
    J Am Chem Soc; 2008 Nov; 130(46):15437-43. PubMed ID: 18954050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.